AMGN compared with ADPT: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

ADPTAdaptive Biotechnologies Corp

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

ADPTAdaptive Biotechnologies Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

ADPT: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

8 more · AMGN chain ›

Shared 0

No shared counterparties.

Only ADPT 6

PFEPfizercustomer

ILMNIlluminasupplier

—Fred Hutchinson Cancer Research Centerunlistedsupplier

—Genentech

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlistedcustomer

2 more · ADPT chain ›

AMGNAmgen Inc

465.45▼−0.12%· post 468.26· delayed

Mkt cap$251.9BRevenue$10.1BQ2 FY26Revenue$36.8BFY25

ADPTAdaptive Biotechnologies Corp

25.04▼−6.02%· post 25.04· delayed

After hoursNov 2 '26delayed

Mkt cap$4.3BRevenue$72MQ2 FY26Revenue$277MFY25

Compare

After hoursNov 2 '26delayed

AMGNAmgen Inc

ADPTAdaptive Biotechnologies Corp

465.45▼−0.12%post 468.26delayed

Price

25.04▼−6.02%post 25.04delayed

$251.9B

Mkt cap

$4.3B

Q2 FY26$10.1B

Revenue

$72MQ2 FY26

FY25$36.8B

Revenue

$277MFY25

AMGN465.45▼−0.12%vsADPT25.04▼−6.02%After hoursNov 2 '26delayed

Price

rebased to 0%

AMGN, solidADPT, dashed